Window of opportunity to enhance EU regulatory systems wide open as EU pharma strategy prioritises stronger EU networks

COVID-19 a lightning rod for major overhaul of EU… 9 July 2020 Urgent call for a structured industry-EU dialogue on reform The…
Opinion piece by Christoph Stoller for Friends of Europe 3 June 2021 "Too much at stake in the EU pharma strategy to…
Inflation drives pharma manufacturing to focus on… 11 October 2022 Inflation is at an all-time high, opening an opportunity for…
European Parliament report calls for increased use of… 24 November 2021 Open